Objectives: The objective of this meta-analysis is to systematically review the evidence on effects of exercise interventions in comparison to usual care with respect to physical fitness, fatigue, quality of life, anxiety and depression in hematopoietic stem cell transplantation patients for a hematological malignancies. And we are more focused on the optimal opportunity to exercise in hematopoietic stem cell transplantation recipients. Method: Databases were searched up to June 2018. We included randomized controlled trials comparing exercise with usual care in adult patients who had a hematologic malignancy. Standard mean differences were calculated and pooled to generate summary effect sizes and 95% confidence intervals. The Cochrane Collaboration Risk of Bias Tool was used to assess the methodological quality of the studies. Results: This meta-analysis showed that exercise had a positive effect on lower muscle strength, fatigue and quality of life and had no effects on patients' cardiorespiratory fitness, upper muscle strength, psychosocial fitness and adverse events. Subgroup analysis showed that exercise had a favorable effect on upper/lower muscle strength, fatigue and quality of life when starting exercise pre-transplant, but exercise had no effects, except on quality of life when starting exercise after transplant. And patients in the pre-transplant exercise group did not exercise more graft vs host disease events nor deaths. Conclusion: Therefore, we can conclude that the optimal timing for the hematopoietic stem cell transplantation recipients to begin exercise training is before transplantation.
Introduction
Hematopoietic stem cell transplantation (HSCT) is the only chance to cure high-risk hematological malignancies (HMs) (1) . Before transplantation, patients usually need to undergo large doses of radiation and chemotherapy to eradicate tumor cells and abnormally proliferating cells in the body. Thereafter, donor hematopoietic stem cells are injected and the patient's hematopoietic system is eventually rebuilt (2) . Globally, more than 60 000 individuals are expected to receive autologous or allogeneic HSCT each year in the world (2) . The establishment of bone marrow and umbilical blood banks have greatly solved the problem of donor stem cell limitation, and more patients are being cured thoroughly by means of HSCT. Advance in HSCT techniques and supportive care have led to dramatic improvements in reducing mortality in patients with high-risk HM. The survival rate of HSCT patients increased from 20% to 70% and nearly 60% of HSCT recipients exhibits long-term survival with no disease (3, 4) .
However, this treatment has many toxic effects, and the most immediate effect may be the decline in physical function (5) (6) (7) . Impairment of physical function is caused by a variety of causes, including the disease itself, systemic radiotherapy, adaptation, anemia and drug therapy (5) . Previous research (8) has found that patients would experience decreased physical performance once the disease was diagnosed, and after treatment, it is often difficult to revert to the previous state. Fatigue is a symptom associated with decreased physical function, as one of the most common complications of HSCT patients (9) (10) (11) (12) . It is reported that there were 41% of patients experienced severe fatigue within 5 years after transplantation (12) , and the fatigue level of survival patients would decreased with time going on. Nevertheless, a study showed that there were still 35% of patients experiencing severe fatigue after 15 years of transplantation (11) . Eventually, the physical side effects are likely to aggravate the psychological side effects, such as anxiety, depression and so on, both will have a negative effect on quality of life (QOL) and recovery (13, 14) .
In the 1980s, the effect of physical exercise on cancer patients was unanimously affirmed internationally. Cunningham et al. (15) had carried out exercise training for the first time in patients with acute leukemia after bone marrow transplantation and proved that exercise training improved patients' physical function. After that, the number of reports of physical exercise programs as a non-pharmacologic adjuvant therapy has been increased before, during or after transplantation in HSCT patients (7, (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . Previous systematic reviews of Persoon (26) and van Haren et al. (27) have confirmed that exercise seems to have a beneficial effect on physical fitness, QOL and fatigue when compared with usual care in patients treated with a HSCT for a HM. The effect of an exercise intervention program on physical fitness is influenced by the mode of exercise, the length of the program, and the frequency, duration and intensity of exercise sessions, as well as by compliance to the protocol. However, due to the low number of studies, exploration of the diversity by subgroup was not possible in the previous meta-analysis. Unfortunately, there is insufficient evidence to conclude what is the best exercise prescription for patients before or after HSCT.
The exercise training opportune moment may be one of the most important problems worth discussing. Different studies have different viewpoints on the opportunity of exercise intervention in HSCT patients. Some studies (19, 20, (23) (24) (25) suggested that it was more difficult to exercise immediately after a transplant, because at this time the hemogram has not returned to normal, accompanied by severe nausea, loss of appetite, fatigue and other symptoms. Morishita et al. (28) argued that exercise would be safe and feasible within 1-2 weeks after transplantation under the supervision of the physical therapist, if the patient did not have severe bleeding or infection symptoms. Wiskemann et al. (18) pointed out that physical function of patients has been impaired before transplantation, so it is necessary to take exercise intervention for HSCT patients as early as possible. Keser et al. (29) also have confirmed that exercise intervention on autologous HSCT patients prior to transplantation would help to mobilize hematopoietic stem cells and improve the success rate of transplants. These have showed that HSCT patients are able to conduct exercise training before or after transplantation, although there is a lack of evidence to show which is the optimal timing for the HSCT patients to begin exercise training.
Hence, the objective of this meta-analysis is to systematically review the evidence on effectiveness of exercise interventions in comparison to usual care with respect to physical fitness, fatigue, QOL, anxiety and depression in HSCT patients for a HM. In particular, we have conducted subgroup analysis for pre/post-transplant, in order to find the best opportunity for exercise intervention.
Methods

Database search
The databases for this meta-analysis include PubMed, Embase, the Cochrane Library and PEDro. The search was updated on June 2018. Keywords used included 'stem cell transplantation/stem cell transplant/ ematopoietic SCT/bone marrow transplant/leukemia/lymphoma/myeloma/hematologic neoplasm/hematologic malignanc', 'exercise therapies/physiotherap/exercise tests/physical therapy/physical therapies/ physical activity/exercises/aerobic training/endurance/strength', 'randomized controlled trial/random'. There are two investigators who completed the literature screening and data extraction independently.
Inclusion/exclusion criteria
A study was eligible if it met the following standards: (i) it was a randomized controlled trial (RCT) published in a peer-reviewed journal; (ii) patients who receive hematopoietic stem cell transplants were ≥18 years old; (iii) the exercise intervention consisted of a physical exercise program or a multimodal intervention aiming to maintain or improve aerobic capacity and/or muscle strength, while the control condition consisted of usual care; (iv) outcome measures assessed physical function, fatigue, QOL, anxiety, depression, and mortality and complications, and objective measurements were used to evaluate physical function; (v) it was a full-text article; (vi) it was published in English. A study was excluded if it was repeated publication or animal experiments.
Quality assessment
The Cochrane Collaboration Risk of Bias Tool (30) was used to assess the risk of bias, in this meta-analysis we focussed on the following domains: randomization sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting and other bias. There are three rating categories available for each item: (i) low risk of bias, which is unlikely to alter the results significantly; (ii) unclear risk of bias, which raises some doubt about the results; (iii) high risk of bias, which seriously weakens confidence in the results. All selected articles were scored by two researchers, if there was a disagreement, then consulted the third researcher and decided the score.
Data analysis methods
RevMan 5.3 for data analysis. For continuous data, if the studies use the same measures, the weighted mean difference will be used to analyze, otherwise standardized mean difference will be used to analyze; for the classified data, the relative risk (RR) value was calculated, and all the analyses calculated 95% confidence intervals. The heterogeneity between the studies is determined by I 2 test, and if there is no statistical heterogeneity (P > 0.1, I 2 < 50%) between the studies, the fixed effect model will be chosen, otherwise (P < 0.1, I
2 > 50%) the random effect model will be selected (30, 31) . P < 0.05 considered statistically significant.
Results
Study, participant and intervention characteristics
Our initial search revealed a total of 5087 records, and the screening progress is shown in Fig. 1 . Ten RCTs (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) were ultimately included. Literature screening and quality assessment were conducted by two researchers, and the results of the methodological quality assessment are shown in Fig. 2 . None of the studies was free from risk of bias. Characteristics of the patient populations and the exercise intervention programs from included studies are presented in Tables 1 and 2 .
Physical fitness
Cardiorespiratory fitness
There are seven studies (16) (17) (18) (20) (21) (22) (23) 
Upper muscle strength
There are seven studies (17) (18) (19) (20) (23) (24) (25) which assessed upper extremity muscle strength. The tests are varied, including dynamometry, 1-RM and grip strength test. Over all, there was no significant effect found for exercise on upper muscle strength (ES = 1.71, 95%CI = −0.53 to 3.96, Fig. 3B ). Subgroup analysis indicated that exercise intervention had a significant positve effect on upper muscle strength among patients starting exercise training before transplantation (ES = 12.45, 95%CI = 2.07 to 22.83, Fig. 3B ), no effect among patients starting exercise after transplantation (ES = 0.32, 95%CI = −0.50 to 1.14, Fig. 3B ).
Lower muscle strength
Eight studies (16) (17) (18) (19) (20) (23) (24) (25) assessed lower muscle strength. The muscle strength tests including dynamometry, 1-RM, timed stair climb and the 30-s chair stand test. The summary effect size for exercise on lower muscle strength was significant (ES = 3.12, 95% CI = 0.42-5.81, Fig. 3C ). Subgroup analysis indicated that exercise intervention had a significant positve effect on lower muscle strength among patients starting exercise training before transplantation (ES = 26.14, 95%CI = 16.69-35.59, Fig. 3C ), but no effects among patients starting exercise after transplantation (ES = 1.11, 95%CI = −0.75 to 2.98, Fig. 3C ).
Fatigue
The effect of exercise on fatigue was assessed in eight studies (16) (17) (18) 20, (22) (23) (24) (25) . 
Quality of life
Seven studies (16) (17) (18) 20, (23) (24) (25) 
Psychosocial well-being
Three studies (17, 18, 23) 
Adverse events
Four studies (16) (17) (18) (19) have reported the incidence of graft vs host disease (GVHD), and three studies (16) (17) (18) 
Discussion
In this meta-analysis, we analyzed the results of 10 RCTs evaluating the effects of exercise intervention on cardiorespiratory fitness, upper/lower muscle strength, fatigue, QOL, and anxiety and depression in patients treated with HSCT for a HM. Although the studies varied in patients' and in exercise intervention, statistical pooling was considered appropriate for studies that measured the same outcome. This meta-analysis showed that exercise intervention had a positive effect on lower muscle strength, fatigue and QOL and had no effects on patients' cardiorespiratory fitness, upper muscle strength, psychosocial fitness and adverse events when compared with usual care. Subgroup analysis showed that exercise had a favorable effect on upper/lower muscle strength, fatigue and QOL when starting exercise before HSCT, but exercise had no effects, except on QOL when starting exercise after HSCT. And patients in the pre-HSCT exercise group did not exercise more GVHD events nor deaths. Therefore, we can conclude that the optimal timing for the HSCT patients to begin exercise training may be before transplantation. This meta-analysis showed that exercise intervention had no effect on patients' cardiorespiratory fitness compared with usual care, whether started the intervention programs before or after transplantation. This result is inconsistent with Persoon et al. (26) . This result may be mainly due to the following two points: first, in the 10 RCTs we included, exercise intervention did not involve breathing training, which resulted in no significant improvement in cardiorespiratory fitness for HSCT patients; second, endurance training is also the key to improve cardiorespiratory function (32), but few studies have focused on endurance training. For instance, three studies (23-25) investigated resistance exercise only, one study (16) combined endurance training with activities of daily living (ADL) training, four studies (18, (20) (21) (22) ) using a combination of endurance training and resistance training, one study (17) combined endurance training with dynamic exercises, progressive relaxation and psychological education, and one study (19) examined a combination of endurance training, active range of motion, stretching exercises and resistive training. However, during the treatment of HSCT, the incidence of lung complications was 40-70%, and about 30% of patients had died from severe lung complications (33) . Therefore, it is necessary for HSCT patients to carry out early respiratory training or endurance training to improve cardiopulmonary function.
This meta-analysis found that exercise intervention was started prior to transplantation rather than after transplantation, could improve patients' upper/lower muscle strength significantly. This result is not consistent with the results of Wiskenmann et al. (18) . Wiskenmann et al. (18) implemented a physical exercise program before, during and continued after discharge hospital but failed to show statistically significant effects on muscle strength, which might be explained by the poor compliance of the self-directed exercise program outside the hospital, as the author mentioned in the limitation that due to the number of missing exercise logs, which limited the assessment of adherence. Intervention benefits were observed during all periods, yet the inpatient period seemed to be the most effective due to the effective supervision and better compliance.
This meta-analysis found that patients who began exercise training before transplantation had less fatigue, which is inconsistent with the results of Jarden et al. (17) . Jarden et al. (17) carried out a multimodal exercise intervention from the first day of hospital admission (7 days before transplant) until the day of discharge and followed at 3 and 6 months. This meta-analysis only included data that were obtained directly following the completion of the intervention (the day of discharge). The failure to show statistically significant improvements between groups in fatigue may be mainly due to the considerable treatment-related symptom burden, complications and the slow restitution process.
This study has confirmed that the sooner patients receive exercise intervention, the better their function will be. During the process of transplant treatment, patients are isolated and are not allowed to leave their rooms for several weeks, plus to the toxic effects of drug therapy on muscle strength or muscle mass, these usually lead to muscle atrophy and decrease in physical performance (9) . Previous study (34) has showed that muscle strength or muscle mass declined within 6 months after transplantation is generally difficult to recover within 5 years. Early physical exercise might help to prevent decline in muscle strength arising from immobility and prolonged bed rest and avoid skeletal muscle atrophy (9, 11, 26, 27) . In addition, exercise also brings other benefits to HSCT patients. Chamorro-Viña et al. (35) found that a moderate intensity exercise program had a positive effect on NK cell recovery early after HSCT in pediatric HSCT patients. Rapidly, stem cell engraftment can promote immune system reconstruction, improve the immune capacity and reduce the incidence of infection and other complications (35, 36) , ultimately improve physical performance and reduce fatigue.
Various on the time of starting exercise intervention in the RCTs. (20); AA (2) EG, exercise group; CG, control group; HM, hematological malignancies; SCT, stem cell transplantation; AML, acute myelocytic leukemia; ALL, acute lymphocytic leukemia; CML, chronic myelocytic leukemia; MM, multiple myeloma; NHL, non-Hodgkin lymphoma; HL, hodgkin lymphoma;CLL, chronic lymphocytic leukemia; MDS, myelodysplastic syndrome; MPS, mucopolysaccharide diseases; AA, aplastic anemia; SAA, Severe aplastic anemia; WM, wadenström macroglobulinemia; PHN, paroxysmal nocturnal hemoglobinuria; MF, myelofibrosis. Continued before transplantation. Duration of exercise seems to be relatively short and vary according to studies before transplantation, but it was associated with a higher physical function. Possible explanations for the result including: first, early exercise intervention can effectively prevent muscle atrophy and decrease in physical performance; second, exercise interventions were implemented before transplantation and continued during hospital admission, the intervention during hospitalization played a very important role in improving physical function of patients (18) . Interventions during hospitalization can effectively prevent muscle atrophy due to prolonged bed rest, besides, patients may benefit more from the higher exercise engagement. Unfortunately, in some of the included studies the adherence to the program was not always clear. We suspect that patients have better compliance with the intervention during hospitalization, for it is convenient for the researchers to supervise the patient effectively, and give the guidance according to the patient's situation in time. However, it is difficult to supervise the patients after discharge, and it is also difficult to ensure the patients have good compliance. It is worth noting that interventions may be more effective if introduced a sufficient time before transplant to allow patients to incorporate these practices into their routines (37) , and early physical exercise should be carried out under the supervision of the physical therapist, the patients have no serious infections or bleeding, pathological fractures and other complications, and the blood cells at a certain level (platelet > 10 9 /l, absolute neutrophil count > 0.5 × 10 9 /l, hemoglobin >80 g/l) (28, 29, 38) .
Futhermore, this meta-analysis identified that exercise had a beneficial effect on QOL, suggesting that improvements in physical fitness may likely yield better life satisfaction and QOL. Nevertheless, this study failed to show that exercise intervention was associated with better psychological well-being. Conversely, Wiskemann et al.'s study (18) found that the exercise group was significantly more anxious than the control group on completion of the study, and a potential explanation could be anxiety caused by the end of the exercise intervention and resulting diminished care by study personnel. In addition, exercise interventions have no effect on the incidence of adverse events, which indicates that exercise is safe in HSCT patients. 
Limitations
Existing opinions that early exercise parallel to medical therapy or immediately after medical therapy would pose a health risk to the patients, and should only be carried out after a disease remission, are now proven to be incorrect. In the meta-analysis, we confirmed that more significant benefits can be gained by starting exercise training before receiving a transplant in HSCT patients. Despite the strengths of this meta-analysis, it has some limitations that should be addressed. First, greater heterogeneity among the included studies for the range of exercise interventions evaluated in studies and the wide variety in outcome instruments used across studies. Second, the 10 studies are all of medium methodological quality, low-quality researches have greater bias in the implementation of stochastic methods and quality control, and other important issues concerning risk of bias including the allocation concealment, and the incomplete data (the presence of selective dropouts and/or no intention to treat analysis performed). Third, this review did not look at the sustainability of the results. In the analysis, we only included data that were obtained directly following the completion of the intervention. Futhermore, due to the low number of studies, the number of studies in each subgroup is relatively small, which may also affect the reliability of the results.
In summary, this meta-analysis confirmed that starting exercise before transplantation, rather than after transplantation, can help patients gain more benefits. Although there are many limitations, the results of this meta-analysis still have some value in the construction of exercise prescription for HSCT patients. Further high-quality studies are necessary to determine the optimal exercise prescription and to assess the clinical relevance of the results.
